

reviewing the said list, validating the prices, identifying any possible
“We take note of the timely submission of the pharmaceutical companies and their commitment to lower medicines prices of their common products by at least 50%,” said Health Secretary Francisco T. Duque III.
“It is good that they met the deadline of the President and that they did not ask for extensions or engaged in any dilatory tactics,” Duque elaborated.
“We are making sure that the 21 molecules are reflected in their proposal and that the price reductions are consistent with the 50% price reduction policy that has been adopted,” stressed Trade Secretary Peter Favila.

In addition to the 21 molecules, the consolidated summary in the letter of undertaking also contained a list of other products offered for voluntary price reductions.